- Ceragon (NASDAQ: CRNT ) reported third quarter EPS of $0.160, $0.07 better than the analyst estimate of $0.090. Revenue for the quarter came in at $102.7M versus the consensus estimate of $102.61M.

Guidance

Ceragon sees FY 2024 revenue of $390.000M-$400.000M versus the analyst consensus of $392.400M.

Ceragon's stock price closed at $2.56. It is down -11.110% in the last 3 months and up 45.450% in the last 12 months.

Ceragon saw 1 positive EPS revisions and 0 negative EPS revisions in the last 90 days. See Ceragon's stock price’s past reactions to earnings here .

According to InvestingPro , Ceragon's Financial Health score is " great performance ".

Check out Ceragon's recent earnings performance , and Ceragon's financials here .

Stay up-to-date on all of the upcoming earnings reports by visiting 's earnings calendar